DMU Grand Rounds: What Your Voice Says About You
Due to the COVID-19 pandemic, this session will be held online only.
DMU faculty, staff, students, residents, and the medical community.
Nearly all of us use our voices on a regular basis to communicate socially, professionally, or even artistically. Laryngeal/voice disorders occur in 3-9% of patients of all ages and can take on many forms, such as a singer having difficulty securely hitting the top note of their singing range to an individual with terminal laryngeal carcinoma. Voice disorders may occur as a result of structural/anatomical factors and/or the improper or ineffective use of the vocal mechanism.
Those attending this presentation will have the opportunity to hear a variety of voices of patients and rate what they hear. These patients will serve as case studies and examples for more in-depth discussion of the anatomy and physiology of voice production and the evaluation and treatment of some common important voice disorders.
Technology advances and newer treatment options will also be highlighted in this multimedia presentation.
- Recognize how laryngeal disorders may affect everyday life.
- Describe the major anatomical and physiological elements of voice production.
- Identify and classify some common voice disorders.
- Assess voice/laryngeal disorders and recommend appropriate referral or treatments.
Hannah Reussner, MSA'25
College of Osteopathic Medicine, Des Moines University
Lee A. Reussner, MD
Founder and Director, Kansas Voice Center
Dr. Reussner has been practicing otolaryngology head and neck surgery since 1994. He did his undergraduate coursework in Lawrence at the University of Kansas, graduating with distinction. He went on to medical school, also at the University of Kansas, where he received his doctorate degree. Upon graduating from medical school, he completed a surgical internship and otolaryngology residency at the University of Rochester School of Medicine in New York. He also contributed to research related to parathyroid gland function from the University of Rochester and on cancer and diseases of the immune system from the University of Kansas. He has been board-certified by the American Board of Otolaryngology and has been an active member of the American Academy of Otolaryngology – Head and Neck Surgery since 1995. Dr. Reussner is the director of the Kansas Voice Center and a member of the Voice Foundation; specializing in the treatment of voice and throat disorders/diseases, including cancer and thyroid disease. He is able to offer the latest minimally invasive surgical approaches for parathyroid surgery as well. He is a Clinical Assistant Professor at the University of Kansas Medical Center. Being a music-lover, he is also serving on the Board of Directors of the Wichita Grand Opera. In addition to medicine, Dr. Reussner enjoys spending time with his wife and two daughters, traveling, and playing basketball.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for 1.0 AMA PRA Category1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- DPM: Des Moines University (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this activity for a maximum of 1.0 continuing education contact hours.
- Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with commercial interest companies to disclose:
- Hannah Reussner, MSA'25, speaker
Relevant to the content of this educational activity, the following individual(s) have the following conflict(s) to disclose:
- Lee A. Reussner, MD, speaker, has no financial relationships but does intend to discuss off-label use of a commercial product.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 1A
- 1.00 CE Contact Hour(s)
- 1.00 CPME
- 1.00 IBON